394 related articles for article (PubMed ID: 10575572)
1. Current treatment for prevention of relapse and recurrence in Crohn's disease.
Prantera C; Scribano ML
Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
[TBL] [Abstract][Full Text] [Related]
2. Medical therapy to reduce postoperative Crohn's disease recurrence.
Achkar JP; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318
[TBL] [Abstract][Full Text] [Related]
3. Review article: chronic active disease and maintaining remission in Crohn's disease.
Kamm MA
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
[TBL] [Abstract][Full Text] [Related]
4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
5. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Kim PS; Zlatanic J; Korelitz BI; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
[TBL] [Abstract][Full Text] [Related]
6. Mesalamine derivatives in the treatment of Crohn's disease.
Harrell LE; Hanauer SB
Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
[TBL] [Abstract][Full Text] [Related]
7. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
[TBL] [Abstract][Full Text] [Related]
8. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
9. Maintenance of surgically induced remission of Crohn's disease.
Froehlich F; Juillerat P; Pittet V; Felley C; Mottet C; Vader JP; Michetti P; Gonvers JJ
Digestion; 2007; 76(2):130-5. PubMed ID: 18239404
[TBL] [Abstract][Full Text] [Related]
10. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
Sandborn WJ; Feagan BG; Lichtenstein GR
Aliment Pharmacol Ther; 2007 Oct; 26(7):987-1003. PubMed ID: 17877506
[TBL] [Abstract][Full Text] [Related]
11. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
12. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
13. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis.
Steinhart AH; Hemphill D; Greenberg GR
Am J Gastroenterol; 1994 Dec; 89(12):2116-24. PubMed ID: 7977225
[TBL] [Abstract][Full Text] [Related]
14. Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.
Hanai H; Iida T; Takeuchi K; Arai H; Arai O; Abe J; Tanaka T; Maruyama Y; Ikeya K; Sugimoto K; Nakamura T; Nakamura K; Watanabe F
Dig Liver Dis; 2012 Aug; 44(8):649-54. PubMed ID: 22542605
[TBL] [Abstract][Full Text] [Related]
15. Recurrence of Crohn's disease in the neoterminal ileum after ileal resection: is prevention therapy possible?
Rutgeerts P
Neth J Med; 1994 Aug; 45(2):60-4. PubMed ID: 7936007
[TBL] [Abstract][Full Text] [Related]
16. Maintenance treatment for Crohn's disease: has the time arrived?
Goldstein F
Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706
[No Abstract] [Full Text] [Related]
17. Maintenance of medically induced remission of Crohn's disease.
Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
[TBL] [Abstract][Full Text] [Related]
18. [Current medical therapies for Crohn's disease in Japan].
Munakata A; Haga Y
Nihon Geka Gakkai Zasshi; 1997 Apr; 98(4):406-11. PubMed ID: 9168493
[TBL] [Abstract][Full Text] [Related]
19. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
Vermeire S; van Assche G; Rutgeerts P
Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
Sutherland LR
CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
